Medicinal potential of ganoderma lucidum

Applied Mycology

Volumn , Issue , 2009, Pages 173-196

  Sliva, Daniel ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b Department of Medicine ^*  (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952009837     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Akihisa, T., Nakamura, Y., Tagata M., Tokuda, H., Yasukawa, K., Uchiyama, E., Suzuki, T. and Kimura, Y. (2007) Anti-inflammatory and anti-tumour-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chemistry and Biodiversity 4, 224-231.
2. Berger, A., Rein, D., Kratky, E., Monnard, I., Hajjaj, H., Meirim, I., Piguet-Welsch, C., Hauser, J., Mace, K. and Niederberger, P. (2004) Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Disease 18, 2.
3. Berovic, M., Habijanic, J., Zore, I., Wraber, B., Hodzar, D., Boh, B. and Pohleven, F. (2003) Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. Journal of Biotechnology 103, 77-86.
4. Buchanan, P.K. (2001) A taxonomic overview of the genus Ganoderma with special reference to species of medicinal and nutraceutical importance. In: Proceedings of the International Symposium on Ganoderma Science, Auckland, New Zealand,pp. 1-8.
5. Cao, Q.-Z. and Lin, Z.-B. (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sciences 78, 1457-1463.
6. Chang, U.-M., Li, C.-H., Lin, L.-I., Huang, C.-P., Kan, L.-S. and Lin, S.-B. (2006) Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sciences 79, 1129-1139.
7. Chen, W.-Q., Luo, S.-H., Ll, H.-Z. and Yang, H. (2005) Effects of Ganoderma lucidum polysaccharides on serum lipids and lipoperoxidation in experimental hyperlipidemic rats. Zhongguo Zhong Yao Za Zhi/Zhongguo Zhongyao Zazhi [China Journal of Chinese Materia Medica] 30, 1358-1360.
8. Eo, S.K., Kim, Y.S., Lee, C.K. and Han, S.S. (1999a) Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. Journal of Ethnopharmacology 68, 129-136.
9. Eo, S.K., Kim, Y.S., Lee, C.K. and Han, S.S. (1999b) Antiherpetic activities of various proteinbound polysaccharides isolated from Ganoderma lucidum. Journal of Ethnopharmacology 68, 175-181.
10. Frye, L.L. and Leonard, D.A. (1999) Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis. Critical Reviews in Biochemistry and Molecular Biology 34, 123-140.
11. Gao, J.-J., Min, B.-S., Ahn, E.-M., Nakamura, N., Lee, H.-K. and Hattori, M. (2002) New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumour cells. Chemical and Pharmaceutical Bulletin 50, 837-840.
12. Gao, J.-J., Nakamura, N., Min, B.-S., Hirakawa, A., Zuo, F. and Hattori, M. (2004) Quantitative determination of bitter principles in specimens of Ganoderma lucidum using highperformance liquid chormatography and its application to the evaluation of Ganoderma products. Chemical Pharmaceutical Bulletin 52, 688-695.
13. Gao, J.L., Yu, Z.L., Li, S.P. and Wang, Y.T. (2005) Research advance on triterpenoids of Ganoderma lucidum. Edible Fungi of China 24, 6-11.
14. Gao, Y. and Zhou, S. (2003) Cancer prevention and treatment by Ganoderma, a mushroom with medical properties. Food Reviews International 19, 275-325.
15. Gao, Y., Lan, J., Dai, X., Ye, J. and Zhou, S. (2004) A phase I/II study of a Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetidae) extract in patients with type II diabetes mellitus. International Journal of Medicinal Mushrooms 6, 3-9.
16. Gao, Y., Tang, W., Dai, X., Gao, H., Chen, G., Ye, J., Chan, E., Koh, H.L., Li, X. and Zhou, S. (2005) Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. Journal of Medicinal Food 8, 159-168.
17. Ha, T.B., Gerhauser, C., Zhang, W.D., Ho-Chong-Line, N. and Fouraste, I. (2000) New lanostanoids from Ganoderma lucidum that induce NAD(P)H:quinone oxidoreductase in cultured hepalcic7 murine hepatoma cells. Planta Medica 66, 681-684.
18. Haak-Frendscho, M., Kino, K., Sone, T. and Jardieu, P. (1993) Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cellular Immunology 150, 101-113.
19. Hajjaj, H., Mace, C., Roberts, M., Niederberger, P. and Fay, L.B. (2005) Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Applied and Environmental Microbiology 71, 3653-3658.
20. He, C.Y., Li, W.D., Guo, S.X., Lin, S.Q. and Lin, Z.B. (2006) Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. Journal of Asian Natural Products Research 8, 705-711.
21. Hong, K.-J., Dunn, D.M., Shen, C.-L. and Pence, B.C. (2004) Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytotherapy Research 18, 768-770.
22. Hsiao, W.L.W., Li, Y.Q., Lee, T.L., Li, N., You, M.M. and Chang, S.T. (2004) Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis 25, 1177-1183.
23. Hsu, H.-Y., Hua, K.-F., Wu, W.-C., Hsu, J., Weng, S.-T., Lin, T.-L., Liu, C.-Y., Hseu, R.-S. and Huang, C.-T. (2008) Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. Journal of Cellular Physiology 215, 15-26.
24. Hu, H., Ahn, N.-S., Yang, X., Lee, Y.-S. and Kang, K.-S. (2002) Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. International Journal of Cancer 102, 250-253.
25. Hua, K.-F., Hsu, H.-Y., Chao, L.K., Chen,S.-T., Yang, W.-B., Hsu, J. and Wong, C.-H. (2007) Ganoderma lucidum polysaccharides enhance CD14 endocytosis of LPS and promote TLR4 signal transduction of cytokine expression. Journal of Cellular Physiology 212, 537-550.
26. Huang, K.C. (1993) The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, Florida.
27. Huie, C.W. and Di, X. (2004) Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 812, 241-257 (http://zipcodezoo.com/Fungi/G/ Ganoderma_amboinense.asp).
28. Iwatsuki, K., Akihisa, T., Tokuda, H., Ukiya, M., Oshikubo, M., Kimura, Y., Asano, T., Nomura, A. and Nishino, H. (2003) Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. Journal of Natural Products 66, 1582-1585.
29. Jiang, J., Slivova, V., Harvey, K., Valachovicova, T. and Sliva, D. (2004a) Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signalling. Nutrition and Cancer 49, 209-216.
30. Jiang J., Slivova, V., Valachovicova, T., Harvey, K. and Sliva, D. (2004b) Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. International Journal of Oncology 24, 1093-1099.
31. Jiang, J., Slivova, V. and Sliva, D. (2006) Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. International Journal of Oncology 29, 695-703.
32. Jiang, J., Grieb, B., Thyagarajan, A. and Sliva, D. (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-kappaB signaling. International Journal of Molecular Medicine 21, 577-584.
33. Kawagishi, H., Mitsunaga, S., Yamawaki, M., Ido, M., Shimada, A., Kinoshita, T., Murata, T., Usui, T., Kimura, A. and Chiba, S. (1997) A lectin from mycelia of the fungus Ganoderma lucidum. Phytochemistry 44, 7-10.
34. Kim, D.H., Shim, S.B., Kim, N.J. and Jang, I.S. (1999) Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biological and Pharmaceutical Bulletin 22, 162-164.
35. Kim, H.S., Kacew, S. and Lee, B.M. (1999) In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 20, 1637-1640.
36. Kim, Y.S., Eo, S.K., Oh, K.W., Lee, C. and Han, S.S. (2000) Antiherpetic activities of acidic protein-bound polysacchride isolated from Ganoderma lucidum alone and in combinations with interferons. Journal of Ethnopharmacology 72, 451-458.
37. Kimura, Y., Taniguchi, M. and Baba, K. (2002) Antitumour and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Research 22, 3309-3318.
38. Kino, K., Mizumoto, K., Sone, T., Yamaji, T., Watanabe, J., Yamashita, A., Yamaoka, K., Shimizu, K., Ko, K. and Tsunoo, H. (1990) An immunomodulating protein, Ling Zhi-8 (LZ-8), prevents insulitis in non-obese diabetic mice. Diabetologia 33, 713-718.
39. Komoda, Y., Shimizu, M., Sonoda, Y. and Sato, Y. (1989) Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chemical and Pharmaceutical Bulletin 37, 531-533.
40. Kubota, T., Asaka, Y., Miura, I. and Mori, H. (1982) Structures of ganoderic Acid A and B, two new lanostane-type bitter triterpenes from Ganoderma lucidum. Helvetica Chimica Acta 65, 611-619.
41. Lakshmi, B., Ajith, T.A., Sheena, N., Gunapalan, N. and Janardhanan, K.K. (2003) Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Teratogenesis, Carcinogenesis, and Mutagenesis (Suppl. 1), 85-97.
42. Lakshmi, B., Ajith, T.A., Jose, N. and Janardhanan, K.K. (2006) Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. Journal of Ethnopharmacology 107, 297-303.
43. Lee, J.M., Kwon, H., Jeong, H., Lee, J.W., Lee, S.Y., Baek, S.J. and Surh, Y.J. (2001) Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Research 15, 245-249.
44. Lee, S., Park, S., Oh, J.W. and Yang, C. (1998) Natural inhibitors for protein prenyltransferase. Planta Medica 64, 303-308.
45. Lee, S.Y. and Rhee, H.M. (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chemical and Pharmaceutical Bulletin 38, 1359-1364.
46. Li, C., Li, Y. and Sun, H.H. (2006) New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Natural Product Research 20, 985-991.
47. Li, C.-H., Chen, P.-Y., Chang, U.-M., Kan, L.-S., Fang, W.-H., Tsai, K.-S. and Lin, S.-B. (2005) Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sciences 77, 252-265.
48. Li, Y.-Q. and Wang, S.-F. (2006) Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnology Letters 28, 837-841.
49. Li, Z., Liu, J. and Zhao, Y. (2005) Possible mechanism underlying the antiherpetic activity of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. Journal of Biochemistry and Molecular Biology 38, 34-40.
50. Liby, K.T., Yore, M.M. and Sporn, M.B. (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nature Reviews Cancer 7, 357-369.
51. Li Khva, R., Vasil'ev, A.V., Orekhov, A.N., Tertov, V.V. and Tutel'ian, V.A. (1989) Antiatherosclerotic properties of higher mushrooms (a clinico-experimental investigation). Voprosy Pitaniia 1, 16-19.
52. Lin, C.N., Tome, W.P. and Won, S.J. (1991) Novel cytotoxic principles of Formosan Ganoderma lucidum. Journal of Natural Products 54, 998-1002.
53. Lin, J.M., Lin, C.C., Chen, M.F., Ujiie, T. and Takada, A. (1995) Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neojaponicum. Journal of Ethnopharmacology 47, 33-41.
54. Lin, K.-I., Kao, Y.-Y., Kuo, H.-K., Yang, W.-B., Chou, A., Lin, H.-H., Yu, A.L. and Wong, C.-H. (2006) Reishi polysaccharides induce immunoglobulin production through the TLR4/ TLR2-mediated induction of transcription factor Blimp-1. Journal of Biological Chemistry 281, 24111-24123.
55. Lin, S.-B., Li, C.-H., Lee, S.-S. and Kan, L.-S. (2003) Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sciences 72, 2381-2390.
56. Lin, W.-C. and Lin, W.-L. (2006) Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World Journal of Gastroenterology 12, 265-270.
57. Lin, Z.-B. (2005) Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. Journal of Pharmacological Sciences 99, 144-153.
58. Lindequist, U., Niedermeyer, T.H.J. and Julich, W.-D. (2005) The pharmacological potential of mushrooms. Evidence-Based Complementary and Alternative Medicine: eCAM 2, 285-299.
59. Liu, J., Yang, F., Ye, L.-B., Yang, X.-J., Timani, K.A., Zheng, Y. and Wang, Y.-H. (2004) Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. Journal of Ethnopharmacology 95, 265-272.
60. Liu, J., Kurashiki, K., Shimizu, K. and Kondo, R. (2006) 5a-Reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. Biological Pharmaceutical Bulletin 29, 392-395.
61. Liu, J., Shimizu, K., Konishi, F., Kumamoto, S. and Kondo, R. (2007) The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorganic and Medicinal Chemistry 15, 4966-4972.
62. Lu, Q.-Y., Jin, Y.-S., Zhang, Q., Zhang, Z., Heber, D., Go, V.L.W., Li, F.P. and Rao, J.Y. (2004) Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Letters 216, 9-20.
63. Min, B.S., Gao, J.J., Nakamura, N. and Hattori, M. (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumour cells. Chemical and Pharmaceutical Bulletin 48, 1026-1033.
64. Miyazaki, T. and Nishijima, M. (1981) Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumour polysaccharide of Ganoderma lucidum. Chemical and Pharmaceutical Bulletin 29, 3611-3616.
65. Mizushina, Y., Takahashi, N., Hanashima, L., Koshino, H., Esumi, Y., Uzawa, J., Sugawara, F. and Sakaguchi, K. (1999) Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum. Bioorganic and Medicinal Chemistry 7, 2047-2052.
66. Morigiwa, A., Kitabatake, K., Fujimoto, Y. and Ikekawa, N. (1986) Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chemical and Pharmaceutical Bulletin 34, 3025-3028.
67. Mothana, R.A.A., Awadh Ali, N.A., Jansen, R., Wegner, U., Mentel, R. and Lindequist, U. (2003) Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 74, 177-180.
68. Niedermeyer, T.H.J., Lindequist, U., Mentel, R., Gordes, D., Schmidt, E., Thurow, K. and Lalk, M. (2005) Antiviral terpenoid constituents of Ganoderma pfeifferi. Journal of Natural Products 68, 1728-1731.
69. Park, E.J., Ko, G., Kim, J. and Sohn, D.H. (1997) Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction [erratum appears in Biol. Pharm. Bull. (1998) 21(6), 649]. Biological and Pharmaceutical Bulletin 20, 417-420.
70. Paterson, R.R.M. (2006) Ganoderma -a therapeutic fungal biofactory. Phytochemistry 67, 1985-2001.
71. Ringler, R.L., Byerrum, R.U., Steven, T.A., Clark, P.P. and Stock, C.C. (1957) Studies on antitumour substances produced by basidiomycetes. Antiobiotic Chemotherapy 7, 1-5.
72. Shiao, M.-S. (2003) Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chemical Record: an Official Publication of the Chemical Society of Japan 3, 172-180.
73. Sliva, D., Sedlak, M., Slivova, V., Valachovicova, T., Lloyd, F.P., Jr. and Ho, N.W.Y. (2003) Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. Journal of Alternative and Complementary Medicine 9, 491-497.
74. Slivova, V., Valachovicova, T., Jiang, J. and Sliva, D. (2004) Ganoderma lucidum inhibits invasiveness of breast cancer cell. Journal of Cancer Integrative Medicine 2, 25-30.
75. Stanley, G., Harvey, K., Slivova, V., Jiang, J. and Sliva, D. (2005) Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochemical and Biophysical Research Communications 330, 46-52.
76. Su, C.Y., Shiao, M.S. and Wang, C.T. (1999) Predominant inhibition of ganodermic acid S on the thromboxane A2-dependent pathway in human platelets response to collagen. Biochimica et Biophysica Acta 1437, 223-234.
77. Sun, J., He, H. and Xie, B.J. (2004) Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. Journal of Agricultural and Food Chemistry 52, 6646-6652.
78. Tanaka, S., Ko, K., Kino, K., Tsuchiya, K., Yamashita, A., Murasugi, A., Sakuma, S. and Tsunoo, H. (1989) Complete amino acid sequence of an immunomodulatory protein, ling zhi-8 (LZ-8). An immunomodulator from a fungus, Ganoderma lucidium, having similarity to immunoglobulin-variable regions. Journal of Biological Chemistry 264, 16372-16377.
79. Tang, W., Liu, J.-W., Zhao, W.-M., Wei, D.-Z. and Zhong, J.-J. (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria-mediated apoptosis in lung cancer cells. Life Sciences 80, 205-211.
80. Tian, Y.-P. and Zhang, K.-C. (2005) Purification and characterization of a novel proteinase A inhibitor from Ganoderma lucidum by submerged fermentation. Enzyme and Microbial Technology 36, 357-361.
81. Thakur, A., Rana, M., Lakhanpal, T.N., Ahmad, A. and Khan, M.I. (2007) Purification and characterization of lectin from fruiting body of Ganoderma lucidum: lectin from Ganoderma lucidum. Biochimica et Biophysica Acta 1770, 1404-1412.
82. Thyagarajan, A., Jiang, J., Hopf, A., Adamec, J. and Sliva, D. (2006) Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. International Journal of Molecular Medicine 18, 657-664.
83. Toth, J.O., Luu, B. and Ourisson, G. (1983) Les acides ganoderiques T and Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporacee). Tetrahedron Letters 24, 1081-1084.
84. van der Hem, L.G., van der Vliet, J.A., Bocken, C.F., Kino, K., Hoitsma, A.J. and Tax, W.J. (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60, 438-443.
85. Wachtel-Galor, S., Tomlinson, B. and Benzie, I.F.F. (2004) Ganoderma lucidum ('Lingzhi'), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study [see comment]. British Journal of Nutrition 91, 263-269.
86. Wang, G., Zhao, J., Liu, J., Huang, Y., Zhong, J.-J. and Tang, W. (2007) Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumour effect of ganoderic acid Me in vivo. International Immunopharmacology 7, 864-870.
87. Wang, H.X. and Ng, T.B. (2006a) Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides 27, 27-30.
88. Wang, H.X. and Ng, T.B. (2006b) A laccase from the medicinal mushroom Ganoderma lucidum. Applied Microbiology and Biotechnology 72, 508-513.
89. Wang, S.Y., Hsu, M.L., Hsu, H.C., Tzeng, C.H., Lee, S.S., Shiao, M.S. and Ho, C.K. (1997) The anti-tumour effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International Journal of Cancer 70, 699-705.
90. Wang, X., Zhao, X., Li, D., Lou, Y.-Q., Lin, Z.-B. and Zhang, G.-L. (2007) Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biological and Pharmaceutical Bulletin 30, 1702-1706.
91. Wang, Y.-Y., Khoo, K.-H., Chen, S.-T., Lin, C.-C., Wong, C.-H. and Lin, C.-H. (2002) Studies on the immuno-modulating and antitumour activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities. Bioorganic and Medicinal Chemistry 10, 1057-1062.
92. Wanmuang, H., Leopairut, J., Kositchaiwat, C., Wananukul, W. and Bunyaratvej, S. (2007) Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Journal of the Medical Association of Thailand 90, 179-181.
93. Wasser, S.P. (2005) Reishi (Ganoderma lucidum). In: Coates P., Blackman, M.R., Cragg, G., Levine, M., Moss, J. and Whit, J. (eds)Encyclopedia of Dietary Supplements. Marcel Dekker, New York,pp. 603-622.
94. Weng, C.-J., Chau, C.-F., Chen, K.-D., Chen, D.-H. and Yen, G.-C. (2007) The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain. Molecular Nutrition and Food Research 51, 1472-1477.
95. Weng, C.-J., Chau, C.-F., Hsieh, Y.-S., Yang, S.-F. and Yen, G.-C. (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29, 147-156.
96. Wu, T.S., Shi, L.S. and Kuo, S.C. (2001) Cytotoxicity of Ganoderma lucidum triterpenes. Journal of Natural Products 64, 1121-1122.
97. Wu, Y.-W., Chen, K.-D. and Lin, W.-C. (2004) Effect of Ganoderma tsugae on chronically carbon tetrachloride-intoxicated rats. American Journal of Chinese Medicine 32, 841-850.
98. Yan, J., Vetvicka, V., Xia, Y., Coxon, A., Carroll, M.C., Mayadas, T.N. and Ross, G.D. (1999) Beta-glucan, a 'specific' biologic response modifier that uses antibodies to target tumours for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). Journal of Immunology 163, 3045-3052.
99. Yang, X.-J., Liu, J., Ye, L.-B., Yang, F., Ye, L., Gao, J.-R. and Wu, Z.-H. (2006) In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World Journal of Gastroenterology 12, 1379-1385.
100. Yeh, C.M., Yeh, C.K., Hsu, X.Y., Luo, Q.M. and Lin, M.Y. (2008) Extracellular expression of a functional recombinant Ganoderma lucidium immunomodulatory protein by Bacillus subtilis and Lactococcus lactis. Applied and Environmental Microbiology 74, 1039-1049.
101. Yue, Q.X., Cao, Z.W., Guan, S.H., Liu, X.H., Tao, L., Wu, W.Y., Li, Y.X., Yang, P.Y., Liu, X. and Guo, D.A. (2008) Proteomic characterization of the cytotoxic mechanism of ganoderic acid D and computer-automated estimation of the possible drug-target network. Molecular and Cellular Proteomics 7, 949-961.
102. Yuen, M.-F., Ip, P., Ng, W.-K. and Lai, C.-L. (2004) Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi). Journal of Hepatology 41, 686-687.
103. Zhang, G.-L., Wang, Y.-H., Ni,W., Ten, H.-L. and Lin, Z.-B. (2002) Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology 8, 728-733.
104. Zhang, H.-N. and Lin, Z.-B. (2004) Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacologica Sinica 25, 191-195.
105. Zhang, H.-N., He, J.-H., Yuan, L. and Lin, Z.-B. (2003) In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sciences 73, 2307-2319.
106. Zhou, X., Lin, J., Yin, Y., Zhao, J., Sun, X. and Tang, K. (2007) Ganodermataceae: natural products and their related pharmacological functions. American Journal of Chinese Medicine 35, 559-574.
107. Zhu, H.S., Yang, X.L., Wang, L.B., Zhao, D.X. and Chen, L. (2000) Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biology and Toxicology 16, 201-206.
108. Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C. (1999) Triterpene antioxidants from Ganoderma lucidum. Phytotherapy Research 13, 529-531.
109. Zhu, X.-L., Chen, A.-F. and Lin, Z.-B. (2007) Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. Journal of Ethnopharmacology 111, 219-226.